In Vitro Performance Testing for Pharmaceutical Products
In recent years, regulatory authorities, including the EMA and FDA, have increasingly supported approaches aimed at reducing the need for unnecessary clinical studies, where scientifically justified, and evaluating product performance through appropriate in vitro methods.
In line with these evolving regulatory expectations, in vitro performance testing has become an increasingly important in pharmaceutical product development and regulatory submissions.
Accordingly, reliable, reproducible, and validated in vitro methods play an increasingly important role in:
• Product development,
• Quality and performance assessment,
• Comparative product evaluation, and
• Supporting regulatory submissions.
–
At WMINOLAB Innovation Laboratory, we perform in vitro performance testing for nasal spray, inhalation, and topical pharmaceutical products using state-of-art technologies and the expertise of our scientific team.
